KVUE Logo

Kenvue Inc. Common Stock (KVUE) Stock Forecast & Price Prediction

Live KVUE Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Consumer Defensive | Household & Personal Products

$21.93

+0.48 (2.24%)

12 Month Price Forecast For KVUE

$21.93
Current Price
$42.05B
Market Cap
17 Ratings
Buy 6
Hold 11
Sell 0
Wall St Analyst Ratings

Distance to KVUE Price Forecasts

+21.1%
To High Target of $26.55
+9.4%
To Median Target of $24.00
-4.2%
To Low Target of $21.00

KVUE Price Momentum

+8.7%
1 Week Change
+5.2%
1 Month Change
+15.1%
1 Year Change
+3.1%
Year-to-Date Change
-10.3%
From 52W High of $24.46
+24.1%
From 52W Low of $17.67

๐Ÿค” Considering Kenvue (KVUE)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 15, 2025 5:07 PM UTC

KVUE Analyst Ratings & Price Targets

Based on our analysis of 18 Wall Street analysts, KVUE has a neutral consensus with a median price target of $24.00 (ranging from $21.00 to $26.55). The overall analyst rating is Buy (7.1/10). Currently trading at $21.93, the median forecast implies a 9.4% upside. This outlook is supported by 6 Buy, 11 Hold, and 0 Sell ratings.

Conversely, the most conservative target is provided by Peter Grom at UBS, suggesting a 4.2% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

KVUE Analyst Consensus

6
Buy
11
Hold
0
Sell

KVUE Price Target Range

Low
$21.00
Average
$24.00
High
$26.55
Current: $21.93

Latest KVUE Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for KVUE.

Date Firm Analyst Rating Change Price Target
Feb 7, 2025 Canaccord Genuity Susan Anderson Buy Maintains $24.00
Feb 7, 2025 UBS Peter Grom Neutral Maintains $21.00
Feb 3, 2025 RBC Capital Nik Modi Sector Perform Reiterates $24.00
Jan 17, 2025 Barclays Lauren Lieberman Equal-Weight Maintains $21.00
Jan 16, 2025 UBS Peter Grom Neutral Maintains $23.00
Jan 15, 2025 Citigroup Filippo Falorni Neutral Maintains $21.00
Jan 6, 2025 Piper Sandler Overweight Upgrade $0.00
Dec 12, 2024 Deutsche Bank Steve Powers Hold Downgrade $24.00
Oct 22, 2024 B of A Securities Anna Lizzul Buy Maintains $27.00
Oct 11, 2024 JP Morgan Andrea Teixeira Overweight Maintains $25.00
Sep 24, 2024 Jefferies Keith Devas Buy Initiates $27.00
Sep 24, 2024 RBC Capital Nik Modi Sector Perform Downgrade $24.00
Sep 23, 2024 Piper Sandler Korinne Wolfmeyer Neutral Maintains $21.00
Aug 7, 2024 UBS Peter Grom Neutral Maintains $22.00
Aug 7, 2024 RBC Capital Nik Modi Outperform Reiterates $24.00
Aug 7, 2024 JP Morgan Andrea Teixeira Overweight Maintains $24.00
Aug 7, 2024 Deutsche Bank Steve Powers Buy Maintains $24.00
Jul 25, 2024 Deutsche Bank Steve Powers Buy Maintains $23.00
Jul 22, 2024 JP Morgan Andrea Teixeira Overweight Maintains $22.00
Jul 11, 2024 Citigroup Neutral Maintains $0.00

Stocks Similar to Kenvue Inc. Common Stock

The following stocks are similar to Kenvue based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Kenvue Inc. Common Stock (KVUE) Financial Data

Kenvue Inc. Common Stock has a market capitalization of $42.05B with a P/E ratio of 40.6x. The company generates $15.46B in trailing twelve-month revenue with a 6.9% profit margin.

Revenue growth is -0.4% quarter-over-quarter, while maintaining an operating margin of +19.9% and return on equity of +9.9%.

Valuation Metrics

Market Cap $42.05B
Enterprise Value $47.53B
P/E Ratio 40.6x
PEG Ratio 18.0x
Price/Sales 2.7x

Growth & Margins

Revenue Growth (YoY) -0.4%
Gross Margin +58.5%
Operating Margin +19.9%
Net Margin +6.9%
EPS Growth -12.6%

Financial Health

Cash/Price Ratio +2.5%
Current Ratio 1.0x
Debt/Equity 82.9x
ROE +9.9%
ROA +6.5%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Kenvue Inc. Common Stock logo

Kenvue Inc. Common Stock (KVUE) Company Overview

About Kenvue Inc. Common Stock

What They Do

Consumer health products across multiple segments.

Business Model

Kenvue Inc. generates revenue through three main segments: Self Care, Skin Health and Beauty, and Essential Health. Each segment offers a range of well-known consumer health products, catering to various health and wellness needs, which allows the company to capture a wide market and generate consistent sales.

Additional Information

Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue leverages established brand names such as Tylenol, Neutrogena, and Listerine, positioning itself as a trusted provider in the consumer health sector.

Company Information

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

22,000

CEO

Mr. Thibaut Mongon

Country

United States

IPO Year

2023

Kenvue Inc. Common Stock (KVUE) Latest News & Analysis

KVUE stock latest news image
Quick Summary

Kenvue Inc. (NYSE: KVUE) executives will present at the CAGNY Conference on February 19, 2025. A live webcast and replay will be available on their investor website.

Why It Matters

Kenvue's leadership presentation at a key industry conference could indicate strategic direction and growth prospects, influencing investor sentiment and stock performance.

Source: Business Wire
Market Sentiment: Neutral
KVUE stock latest news image
Quick Summary

Kenvue, with a market cap of $37.96 billion, faces profitability challenges despite revenue growth. Recent results show declining net income and EBITDA, leading to a 'hold' rating.

Why It Matters

Kenvue's mixed financial results and struggles with profitability despite growth signal potential risks. A low valuation may attract interest, but weak fundamentals suggest caution.

Source: Seeking Alpha
Market Sentiment: Neutral
KVUE stock latest news image
Quick Summary

Kenvue's stock has underperformed post-IPO with reduced guidance for 2023 and 2024. Strong brands and activist investor support suggest potential for future improvement.

Why It Matters

Kenvue's stock dip and guidance cuts raise concerns, but strong brands and activist investor backing hint at potential recovery, making it a stock to watch for future growth.

Source: Seeking Alpha
Market Sentiment: Neutral
KVUE stock latest news image
Quick Summary

Kenvue projected 2025 adjusted profit below Wall Street estimates due to a stronger dollar and weak demand for cough and cold products like Tylenol and Benadryl.

Why It Matters

Kenvue's lower 2025 profit forecast indicates potential revenue challenges, impacting investor confidence and possibly leading to stock price declines.

Source: Reuters
Market Sentiment: Negative
KVUE stock latest news image
Quick Summary

Kenvue (KVUE) reported mixed Q4 and full-year earnings, with adjusted EPS of $0.26 meeting market consensus on February 6.

Why It Matters

Kenvue's mixed earnings report signals stability with EPS meeting expectations, but highlights potential concerns about growth, influencing investor confidence and stock performance.

Source: The Motley Fool
Market Sentiment: Neutral
KVUE stock latest news image
Quick Summary

Kenvue, Inc. (NYSE:KVUE) will hold its Q4 2024 earnings conference call on February 6, 2025, at 8:00 AM ET, featuring key executives and analysts from major financial institutions.

Why It Matters

Kenvue's earnings call indicates financial performance insights, impacting stock valuation and investor sentiment. Analyst participation suggests significant interest in the company's outlook and strategy.

Source: Seeking Alpha
Market Sentiment: Neutral

Frequently Asked Questions About KVUE Stock

What is Kenvue Inc. Common Stock's (KVUE) stock forecast for 2025?

Based on our analysis of 18 Wall Street analysts, Kenvue Inc. Common Stock (KVUE) has a median price target of $24.00. The highest price target is $26.55 and the lowest is $21.00.

Is KVUE stock a good investment in 2025?

According to current analyst ratings, KVUE has 6 Buy ratings, 11 Hold ratings, and 0 Sell ratings. The stock is currently trading at $21.93. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for KVUE stock?

Wall Street analysts predict KVUE stock could reach $24.00 in the next 12 months. This represents a 9.4% increase from the current price of $21.93. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Kenvue Inc. Common Stock's business model?

Kenvue Inc. generates revenue through three main segments: Self Care, Skin Health and Beauty, and Essential Health. Each segment offers a range of well-known consumer health products, catering to various health and wellness needs, which allows the company to capture a wide market and generate consistent sales.

What is the highest forecasted price for KVUE Kenvue Inc. Common Stock?

The highest price target for KVUE is $26.55 from at , which represents a 21.1% increase from the current price of $21.93.

What is the lowest forecasted price for KVUE Kenvue Inc. Common Stock?

The lowest price target for KVUE is $21.00 from Peter Grom at UBS, which represents a -4.2% decrease from the current price of $21.93.

What is the overall KVUE consensus from analysts for Kenvue Inc. Common Stock?

The overall analyst consensus for KVUE is neutral. Out of 18 Wall Street analysts, 6 rate it as Buy, 11 as Hold, and 0 as Sell, with a median price target of $24.00.

How accurate are KVUE stock price projections?

Stock price projections, including those for Kenvue Inc. Common Stock, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.